Drug Details

Belumosudil is an oral selective rho-associated coiled-coil–containing protein kinase-2 (ROCK2) inhibitor. 

Study Purpose

The purpose of this study is to see if taking the study drug, Belumosudil, for 52 weeks in addition to your usual care and medication will prevent Chronic Lung Allograft Dysfunction (CLAD) in participants who have a lung biopsy that shows evidence of rejection or inflammation to the transplanted lung(s).

Find a Clinical Trial